Navigation Links
ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco

SACRAMENTO, Calif., Feb. 28 /PRNewswire/ -- ROBODOC, a Curexo Technology Company, and newly formed division of Curexo, Inc., announced today that they will be exhibiting at the upcoming American Association of Orthopaedic Surgeons Annual Conference being held at the Moscone Center in San Francisco, March 5th through the 7th; Hall D, Booth #4470.

"Because the ROBODOC Product brand has a strong worldwide recognition, Curexo Inc. has decided to name the company ROBODOC, a Curexo Technology Company," said Dr. Ramesh Trivedi, President and CEO.

"We are looking forward to attending the AAOS meeting in San Francisco to present the only fully automated Robotics technology to the US orthopaedic community even though, it has been available for many years to the surgeons throughout the world. Combining our pioneering work with many years of experience of routinely performing joint replacement surgeries overseas and the strong support of our new partner, Curexo Inc., strongly positions us to offer a unique solution for the current and future challenges in orthopaedic surgery. Together with our partner Curexo, Inc. we have developed strong technical and marketing initiatives for the future, and are prepared to move forward into the US Market," added Dr. Trivedi.


ROBODOC, develops, manufacturers, and markets a fully automated surgical robotic system for orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robot for use in hip and knee replacement as well as other orthopaedic surgeries. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures to assist the surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.

ROBODOC(R) and ORTHODOC(R) are registered trade marks of Curexo Technology Corporation
1433 N. Market Blvd., Suite 1, Sacramento, CA 95834

Contact: Dr. R.C. Trivedi

President & CEO


A Curexo Technology Company

916 285 9943 x 527


Ms. Sheila Shah

Marketing Communications


A Curexo Technology Company

916 285 9943 X 510

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference
2. Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
3. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
4. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
5. Attagenes Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods
6. Newly Published EPA RCRA Method 6800 Supports AIT Technology
7. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
8. Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology
9. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
10. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):